The role of neck dissection (ND) after neoadjuvant chemotherapy (CT) with docetaxel, cisplatin and 5-fluorouracil (TPF) followed by concomitant chemoradiation (CR) with cisplatin for patients with locoregionally advanced squamous cell carcinomas of the head and neck (SCCHN)

被引:0
|
作者
da Silva, I. Pires [1 ]
Mouta, J. [1 ]
Winckler, P. [1 ]
Costa, D. [1 ]
Netto, E. [1 ]
Santos, J. Rosa [1 ]
Magalhaes, M. [1 ]
Alexandre, T. [1 ]
Sargento, I. [1 ]
Ferreira, M. [1 ]
Moreira, A. [1 ]
机构
[1] Inst Portugues Oncol Francisco Gentil, Clin Oncol, Lisbon, Portugal
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2818
引用
收藏
页码:S563 / S564
页数:2
相关论文
共 50 条
  • [21] Rate of complete pathological responses (pCR) to docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy in patients with newly diagnosed, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Haddad, RI
    Tishler, R
    Wirth, L
    Norris, C
    Goguen, L
    Sullivan, C
    O'Donnell, L
    Li, Y
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 502S - 502S
  • [22] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Baghi, M
    Hambek, M
    Wagenblast, J
    May, A
    Wolfgang
    Gstoettner
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
  • [23] Randomized phase II trial of concomitant chemoradiotherapy (CT/RT) versus docetaxel, cisplatin and 5-fluorouracil (TPF) followed by concomitant CT/RT in locally advanced head and neck squamous cell carcinoma (HNSCC)
    Turcato, G.
    Buffoli, A.
    Loreggian, L.
    Gava, A.
    Campostrini, F.
    Gardani, G.
    Polsinelli, M.
    Tomio, L.
    Villa, B.
    Paccagnella, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S192 - S192
  • [24] INDUCTION CHEMOTHERAPY USING DOCETAXEL, CISPLATIN AND FLUOROURACIL (TPF) FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY VS THE SAME CONCOMITANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (LASCCHN)
    El-Sadda, W.
    Halim, I. Abdel
    Abul Khair, K.
    Latif, R. Abdel
    ANNALS OF ONCOLOGY, 2012, 23 : 341 - 341
  • [25] Locally advanced head and neck squamous cell carcinomas treated with TPF(docetaxel, cisplatin, 5-FU) induction chemotherapy
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Honma, Rio
    Takeuchi, Satoshi
    Tsuchiya, Kazuhiko
    Shirato, Hiroki
    Homma, Akihiro
    Fukuda, Satoshi
    Akita, Hirotoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 90 - 90
  • [26] Neoadjuvant chemotherapy with 5-Fluorouracil infusion and Cisplatin for untreated locally advanced squamous cell carcinoma of head and neck
    Choi, KK
    Kim, MJ
    Kim, KW
    Cho, YS
    Bang, YJ
    Heo, DS
    3RD ASIAN CONGRESS ON ORAL AND MAXILLOFACIAL SURGERY, 1996, : 189 - 193
  • [27] CISPLATIN - 5-FLUOROURACIL CHEMOTHERAPY FOR ADVANCED INOPERABLE SQUAMOUS CARCINOMA OF THE HEAD AND NECK
    JOHNSON, JT
    MAYERNIK, DG
    MYERS, EN
    NOLAN, TA
    SCHRAMM, VL
    SIGLER, BS
    WAGNER, RL
    HEAD & NECK SURGERY, 1987, 9 (06): : 336 - 340
  • [28] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, Hideaki
    Tsukuda, Mamoru
    Watai, Kiichi
    ANNALS OF ONCOLOGY, 2006, 17 : 181 - 181
  • [29] Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas
    Iop, A
    Cartei, G
    Vigevani, E
    Clocchiatti, L
    Mansutti, M
    Sibau, AM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (05): : 515 - 518
  • [30] Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
    Fayette, Jerome
    Fontaine-Delaruelle, Clara
    Ambrun, Alexis
    Daveau, Clementine
    Poupart, Marc
    Ramade, Antoine
    Zrounba, Philippe
    Neidhardt, Eve-Marie
    Peron, Julien
    Diallo, Alpha
    Ceruse, Philippe
    ONCOTARGET, 2016, 7 (24) : 37297 - 37304